These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
152 related articles for article (PubMed ID: 34731936)
1. Whole-Exome Sequencing in Papillary Microcarcinoma: Potential Early Biomarkers of Lateral Lymph Node Metastasis. Kim M; Kwon CH; Jang MH; Kim JM; Kim EH; Jeon YK; Kim SS; Choi KU; Kim IJ; Park M; Kim BH Endocrinol Metab (Seoul); 2021 Oct; 36(5):1086-1094. PubMed ID: 34731936 [TBL] [Abstract][Full Text] [Related]
2. Extensive lymphatic spread of papillary thyroid microcarcinoma is associated with an increase in expression of genes involved in epithelial-mesenchymal transition and cancer stem cell-like properties. Lee S; Bae JS; Jung CK; Chung WY Cancer Med; 2019 Nov; 8(15):6528-6537. PubMed ID: 31498560 [TBL] [Abstract][Full Text] [Related]
3. Clinicopathological Features and Molecular Signatures of Lateral Neck Lymph Node Metastasis in Papillary Thyroid Microcarcinoma. Lim J; Lee HS; Heo JH; Song YS Endocrinol Metab (Seoul); 2024 Apr; 39(2):324-333. PubMed ID: 38572535 [TBL] [Abstract][Full Text] [Related]
4. Mutational profile of papillary thyroid microcarcinoma with extensive lymph node metastasis. Jeon MJ; Chun SM; Lee JY; Choi KW; Kim D; Kim TY; Jang SJ; Kim WB; Shong YK; Song DE; Kim WG Endocrine; 2019 Apr; 64(1):130-138. PubMed ID: 30645724 [TBL] [Abstract][Full Text] [Related]
5. Features of papillary thyroid microcarcinoma associated with lateral cervical lymph node metastasis. Jeon MJ; Chung MS; Kwon H; Kim M; Park S; Baek JH; Song DE; Sung TY; Hong SJ; Kim TY; Kim WB; Shong YK; Lee JH; Kim WG Clin Endocrinol (Oxf); 2017 Jun; 86(6):845-851. PubMed ID: 28273370 [TBL] [Abstract][Full Text] [Related]
6. The role of the tumor microenvironment in papillary thyroid microcarcinoma nodal metastasis. Kim M; Kwon CH; Kim BH Endocr Relat Cancer; 2024 Aug; 31(8):. PubMed ID: 38768280 [TBL] [Abstract][Full Text] [Related]
7. Predictors of lateral lymph node metastasis and skip metastasis in patients with papillary thyroid microcarcinoma. Yoon JH; Park JY; Hong AR; Kim HK; Kang HC Front Endocrinol (Lausanne); 2024; 15():1392247. PubMed ID: 39015180 [TBL] [Abstract][Full Text] [Related]
8. Deciphering novel biomarkers of lymph node metastasis of thyroid papillary microcarcinoma using proteomic analysis of ultrasound-guided fine-needle aspiration biopsy samples. Lin P; Yao Z; Sun Y; Li W; Liu Y; Liang K; Liu Y; Qin J; Hou X; Chen L J Proteomics; 2019 Jul; 204():103414. PubMed ID: 31195151 [TBL] [Abstract][Full Text] [Related]
9. Analysis of differential BRAF(V600E) mutational status in high aggressive papillary thyroid microcarcinoma. Lee X; Gao M; Ji Y; Yu Y; Feng Y; Li Y; Zhang Y; Cheng W; Zhao W Ann Surg Oncol; 2009 Feb; 16(2):240-5. PubMed ID: 19034577 [TBL] [Abstract][Full Text] [Related]
10. The model for predicting the central lymph node metastasis in cN0 papillary thyroid microcarcinoma with Hashimoto's thyroiditis. Lin Y; Cui N; Li F; Wang Y; Wang B Front Endocrinol (Lausanne); 2024; 15():1330896. PubMed ID: 38745958 [TBL] [Abstract][Full Text] [Related]
11. Cell adhesion-related gene somatic mutations are enriched in aggressive papillary thyroid microcarcinomas. Song J; Wu S; Xia X; Wang Y; Fan Y; Yang Z J Transl Med; 2018 Oct; 16(1):269. PubMed ID: 30285776 [TBL] [Abstract][Full Text] [Related]
12. Can Cervical Lymph Node Metastasis Increase the Risk of Distant Metastasis in Papillary Thyroid Carcinoma? Wang W; Ding Y; Jiang W; Li X Front Endocrinol (Lausanne); 2022; 13():917794. PubMed ID: 35813656 [TBL] [Abstract][Full Text] [Related]
13. Extent of lateral neck dissection for papillary thyroid microcarcinomas. Lee JH; Chun YS; Chung YS Head Neck; 2019 May; 41(5):1367-1371. PubMed ID: 30536753 [TBL] [Abstract][Full Text] [Related]
14. Latero-cervical lymph node metastases (N1b) represent an additional risk factor for papillary thyroid cancer outcome. Sapuppo G; Palermo F; Russo M; Tavarelli M; Masucci R; Squatrito S; Vigneri R; Pellegriti G J Endocrinol Invest; 2017 Dec; 40(12):1355-1363. PubMed ID: 28646475 [TBL] [Abstract][Full Text] [Related]
15. Feasibility of whole-exome sequencing in fine-needle aspiration specimens of papillary thyroid microcarcinoma for the identification of novel gene mutations. Ma L; Gao L; Hu Y; Li X; Liu C; Ji J; Shi X; Pan A; An Y; Luo N; Xia Y; Jiang Y Clin Genet; 2024 May; 105(5):567-572. PubMed ID: 38326996 [TBL] [Abstract][Full Text] [Related]
16. Real-Time PCR Cycle Threshold Values for the BRAFV600E Mutation in Papillary Thyroid Microcarcinoma May Be Associated With Central Lymph Node Metastasis: A Retrospective Study. Park VY; Kim EK; Lee HS; Moon HJ; Yoon JH; Kwak JY Medicine (Baltimore); 2015 Jul; 94(28):e1149. PubMed ID: 26181555 [TBL] [Abstract][Full Text] [Related]
17. Optimal value of lymph node ratio and metastatic lymph node size to predict risk of recurrence in pediatric thyroid cancer with lateral neck metastasis. Back K; Kim TH; Lee J; Kim JS; Choe JH; Oh YL; Cho A; Kim JH J Pediatr Surg; 2023 Mar; 58(3):568-573. PubMed ID: 35973863 [TBL] [Abstract][Full Text] [Related]
18. Clinical predictors of lymph node metastasis and survival rate in papillary thyroid microcarcinoma: analysis of 3607 patients at a single institution. Xu Y; Xu L; Wang J J Surg Res; 2018 Jan; 221():128-134. PubMed ID: 29229118 [TBL] [Abstract][Full Text] [Related]
19. Papillary microcarcinoma of the thyroid: clinical characteristics and BRAF(V600E) mutational status of 977 cases. Zheng X; Wei S; Han Y; Li Y; Yu Y; Yun X; Ren X; Gao M Ann Surg Oncol; 2013 Jul; 20(7):2266-73. PubMed ID: 23370668 [TBL] [Abstract][Full Text] [Related]
20. Endoplasmic reticulum aminopeptidase 2 is highly expressed in papillary thyroid microcarcinoma with cervical lymph node metastasis. Kim WY; Lee JB; Kim HY; Woo SU; Son GS; Bae JW J Cancer Res Ther; 2015; 11(2):443-6. PubMed ID: 26148615 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]